Coronavirus Update: AstraZeneca To Develop Oxford’s Vaccine, Adaptive Trial Delivers Remdesivir's Good News

More Details From China's Negative Results In Lancet

 
• By Scrip Team
  
AZ_Courtyard
AstraZeneca's new HQ is in Cambridge, but has a longstanding basic research relationship with the University of Oxford
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip